Literature DB >> 29042316

Repeated exposure to 3,4-methylenedioxypyrovalerone and cocaine produces locomotor sensitization with minimal effects on brain monoamines.

Robert J Kohler1, Shane A Perrine2, Lisa E Baker3.   

Abstract

Synthetic cathinones, known as "bath salts" on the illicit drug market, pose a significant public health concern. 3,4-Methylenedioxypyrovalerone (MDPV), one of several popular constituents of illicit bath salts, produces similar pharmacological actions to cocaine, albeit with greater potency and efficacy. The present study sought to characterize behavioral and neurochemical effects of repeated exposure to MDPV alone and in combination with cocaine. Male Sprague-Dawley rats were randomly assigned to one the following four treatments, administered once daily for seven days: 1 mg/kg MDPV, 5 mg/kg cocaine, 1 mg/kg MDPV +5 mg/kg cocaine, or saline. Locomotor activity was assessed for 1 h immediately before and 1 h immediately after injections on days 1 and 6. Brains were harvested 20 min after the final injection on day 7 and brain tissue punches were obtained to determine monoamine content within the anterior striatum, medial prefrontal cortex, and nucleus accumbens using High-Performance Liquid Chromatography (HPLC). Drug-induced increases in horizontal activity were significantly greater on treatment day 6 compared to treatment day 1 in all three drug treatment groups in comparison to the saline control group. MDPV produced significantly higher increases in activity compared to either saline or cocaine, although concurrent treatment with MDPV and cocaine produced sub-additive effects. Neurochemical analyses provided no evidence of alterations in total monoamine content following repeated administration of MDPV, cocaine, or the MDPV + COC mixture. Further investigations targeting possible changes in DA receptor sensitivity following repeated exposure to MDPV may help elucidate the mechanistic changes responsible for MDPV-induced behavioral sensitization. This article is part of the Special Issue entitled 'Designer Drugs and Legal Highs.'
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Behavioral sensitization; Cocaine; Dopamine; Locomotor activity; MDPV; Medial prefrontal cortex; Monoamines; Nucleus accumbens; Rats; Serotonin; Striatum

Mesh:

Substances:

Year:  2017        PMID: 29042316      PMCID: PMC8853635          DOI: 10.1016/j.neuropharm.2017.10.019

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  23 in total

1.  Death following recreational use of designer drug "bath salts" containing 3,4-Methylenedioxypyrovalerone (MDPV).

Authors:  Brittany L Murray; Christine M Murphy; Michael C Beuhler
Journal:  J Med Toxicol       Date:  2012-03

2.  Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States.

Authors:  Henry A Spiller; Mark L Ryan; Robert G Weston; Joanne Jansen
Journal:  Clin Toxicol (Phila)       Date:  2011-07       Impact factor: 4.467

Review 3.  Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP).

Authors:  Richard A Glennon; Richard Young
Journal:  Brain Res Bull       Date:  2016-04-29       Impact factor: 4.077

4.  Sensitization to the locomotor stimulant effects of "bath salt" constituents, 4-methylmethcathinone (4-MMC) and 3,4-methylenedioxypyrovalerone (MDPV), in male Sprague-Dawley rats.

Authors:  Michael D Berquist; Haily K Traxler; Alyssa M Mahler; Lisa E Baker
Journal:  Drug Alcohol Depend       Date:  2016-05-09       Impact factor: 4.492

5.  Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Lucas R Watterson; Peter R Kufahl; Natali E Nemirovsky; Kaveish Sewalia; Megan Grabenauer; Brian F Thomas; Julie A Marusich; Scott Wegner; M Foster Olive
Journal:  Addict Biol       Date:  2012-07-11       Impact factor: 4.280

6.  Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.

Authors:  Michael H Baumann; John S Partilla; Kurt R Lehner; Eric B Thorndike; Alexander F Hoffman; Marion Holy; Richard B Rothman; Steven R Goldberg; Carl R Lupica; Harald H Sitte; Simon D Brandt; Srihari R Tella; Nicholas V Cozzi; Charles W Schindler
Journal:  Neuropsychopharmacology       Date:  2012-10-17       Impact factor: 7.853

7.  The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats.

Authors:  S M Aarde; P K Huang; K M Creehan; T J Dickerson; M A Taffe
Journal:  Neuropharmacology       Date:  2013-04-15       Impact factor: 5.250

8.  Mephedrone, methylone and 3,4-methylenedioxypyrovalerone (MDPV) induce conditioned place preference in mice.

Authors:  Louise Karlsson; Mikael Andersson; Robert Kronstrand; Fredrik C Kugelberg
Journal:  Basic Clin Pharmacol Toxicol       Date:  2014-05-06       Impact factor: 4.080

9.  Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals.

Authors:  P W Kalivas; P Duffy
Journal:  J Neurosci       Date:  1993-01       Impact factor: 6.167

10.  Behavioral sensitization to cocaine is associated with increased AMPA receptor surface expression in the nucleus accumbens.

Authors:  Amy C Boudreau; Marina E Wolf
Journal:  J Neurosci       Date:  2005-10-05       Impact factor: 6.709

View more
  9 in total

1.  Acute and repeated administration of MDPV increases aggressive behavior in mice: forensic implications.

Authors:  Fabio De-Giorgio; Sabrine Bilel; Andrea Ossato; Micaela Tirri; Raffaella Arfè; Federica Foti; Giovanni Serpelloni; Paolo Frisoni; Margherita Neri; Matteo Marti
Journal:  Int J Legal Med       Date:  2019-06-01       Impact factor: 2.686

2.  Synthetic cathinone MDPV enhances reward function through purinergic P2X7 receptor-dependent pathway and increases P2X7 gene expression in nucleus accumbens.

Authors:  Taylor A Gentile; Steven J Simmons; Christopher S Tallarida; Shu Su; Slava Rom; Mia N Watson; Allen B Reitz; Raghava Potula; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2019-01-31       Impact factor: 4.492

3.  Low-normal doses of methiopropamine induce aggressive behaviour in mice.

Authors:  Federica Foti; Sabrine Bilel; Fabio De-Giorgio; Matteo Marti; Micaela Tirri; Raffaella Arfè; Federica Boccuto; Tatiana Bernardi; Giovanni Serpelloni
Journal:  Psychopharmacology (Berl)       Date:  2021-03-26       Impact factor: 4.530

4.  Chemokines and 'bath salts': CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats.

Authors:  Chicora F Oliver; Steven J Simmons; Sunil U Nayak; Garry R Smith; Allen B Reitz; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2018-03-10       Impact factor: 4.492

5.  Cytotoxic Effects of 3,4-Catechol-PV (One Major MDPV Metabolite) on Human Dopaminergic SH-SY5Y Cells.

Authors:  Teresa Coccini; Sarah Vecchio; Marta Crevani; Uliana De Simone
Journal:  Neurotox Res       Date:  2018-06-22       Impact factor: 3.911

6.  Repeated administration of synthetic cathinone 3,4-methylenedioxypyrovalerone persistently increases impulsive choice in rats.

Authors:  William S Hyatt; Michael D Berquist; Neha M Chitre; Lauren N Russell; Kenner C Rice; Kevin S Murnane; William E Fantegrossi
Journal:  Behav Pharmacol       Date:  2019-10       Impact factor: 2.277

7.  The synthetic cathinone 3,4-methylenedioxypyrovalerone increases impulsive action in rats.

Authors:  William S Hyatt; Caitlin E Hirsh; Lauren N Russell; Neha M Chitre; Kevin S Murnane; Kenner C Rice; William E Fantegrossi
Journal:  Behav Pharmacol       Date:  2020-06       Impact factor: 2.277

8.  3,4-Methylenedioxypyrovalerone (MDPV) Sensing Based on Electropolymerized Molecularly Imprinted Polymers on Silver Nanoparticles and Carboxylated Multi-Walled Carbon Nanotubes.

Authors:  Rosa A S Couto; Constantino Coelho; Bassim Mounssef; Sara F de A Morais; Camila D Lima; Wallans T P Dos Santos; Félix Carvalho; Cecília M P Rodrigues; Ataualpa A C Braga; Luís Moreira Gonçalves; M Beatriz Quinaz
Journal:  Nanomaterials (Basel)       Date:  2021-02-01       Impact factor: 5.076

9.  Behavioral Effects of 4-CMC and 4-MeO-PVP in DBA/2J Mice After Acute and Intermittent Administration and Following Withdrawal from Intermittent 14-Day Treatment.

Authors:  Jakub Wojcieszak; Katarzyna Kuczyńska; Jolanta B Zawilska
Journal:  Neurotox Res       Date:  2021-01-11       Impact factor: 3.978

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.